Nakanuma Shinichi, Miyashita Tomoharu, Hayashi Hironori, Tajima Hidehiro, Takamura Hiroyuki, Tsukada Tomoya, Okamoto Koichi, Sakai Seisho, Makino Isamu, Kinoshita Jun, Nakamura Keishi, Oyama Katsunobu, Inokuchi Masafumi, Nakagawara Hisatoshi, Ninomiya Itasu, Kitagawa Hirohisa, Fushida Sachio, Fujimura Takashi, Ohta Tetsuo
Department of Gastroenterologic Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan.
Exp Ther Med. 2015 Apr;9(4):1119-1124. doi: 10.3892/etm.2015.2245. Epub 2015 Feb 2.
Sinusoidal obstruction syndrome (SOS), previously known as veno-occlusive disease, is relatively rare subsequent to liver transplantation (LT). SOS refractory to medical therapy, however, can result in centrilobular fibrosis, portal hypertension and liver failure. Although sinusoidal endothelial cell damage around central venules (zone 3) occurs early in the development of SOS, the detailed mechanism of SOS development and its association with thrombocytopenia are not yet completely understood. The present report describes a patient who experienced SOS with unexplained thrombocytopenia following living donor LT. The progression of SOS resulted in graft dysfunction and the patient succumbed. The presence of platelets in the liver allograft was assayed immunohistochemically using antibody to the platelet marker cluster of differentiation 42b (platelet glycoprotein Ib). Platelet aggregates were found attached to hepatocytes along the sinusoid and within the cytoplasm of hepatocytes, particularly in zone 3. By contrast, no staining was observed in zone 1. These findings suggested that extravasated platelet aggregation in the space of Disse and the phagocytosis of platelets by hepatocytes were initiated by sinusoidal endothelial cell damage due to the toxicity of the immunosuppressant tacrolimus or a corticosteroid pulse, and that platelet activation and degranulation may be at least partially involved in the mechanism responsible for SOS.
窦性阻塞综合征(SOS),以前称为肝小静脉闭塞病,在肝移植(LT)后相对少见。然而,对药物治疗难治的SOS可导致小叶中心纤维化、门静脉高压和肝衰竭。尽管中央小静脉周围(3区)的肝窦内皮细胞损伤在SOS发展早期就已出现,但SOS发展的详细机制及其与血小板减少症的关联尚未完全明确。本报告描述了一名活体供肝肝移植后发生SOS并伴有不明原因血小板减少症的患者。SOS的进展导致移植物功能障碍,患者最终死亡。使用针对血小板标志物分化簇42b(血小板糖蛋白Ib)的抗体,通过免疫组织化学方法检测肝移植供肝中的血小板。发现血小板聚集体附着于肝窦周围的肝细胞以及肝细胞胞质内,尤其是在3区。相比之下,1区未观察到染色。这些发现表明,由于免疫抑制剂他克莫司或皮质类固醇脉冲的毒性导致肝窦内皮细胞损伤,从而引发了狄氏间隙内渗出的血小板聚集以及肝细胞对血小板的吞噬作用,并且血小板活化和脱颗粒可能至少部分参与了SOS的发病机制。